Larvol Delta - KEYNOTEE29-A-Study-Evaluating-AB248-Alone-or-in-Combination-With-Pembrolizumab-in-Adult-Patients-With-Solid-Tumors

AB248 - Asher Biotherap

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT05653882

Jan 1, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next